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Abstract 
Mutations in collagen II are associated with spondyloepiphyseal dysplasia, a group of heritable diseases 
whose common features include aberrations of skeletal growth. The mechanisms through which 
mutations in collagen II affect the cartilaginous tissues are complex and include both intracellular and 
extracellular processes. One of those mechanisms involves cellular stress caused by excessive 
accumulation of misfolded collagen II mutants. We investigated whether stabilizing the structure of 
thermolabile R789C and R992C collagen II mutants would improve their secretion from cells, thereby 
reducing cellular stress and apoptosis. Employing glycerol and trimethylamine N-oxide (TMAO), 
chemicals that increase the thermostability of collagen triple helices, we demonstrated that those 
compounds function as chaperones and stabilize the R789C and R992C mutants, accelerate their 
secretion, and improve cell survival. Our study provides a scientific basis for considering misfolded triple 
helices of collagen mutants a target for reducing the deleterious effects caused by their excessive 
intracellular accumulation. 
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Introduction 
Collagen II is a component of heterotypic fibrils which form scaffolds of mature cartilaginous tissues 
and provide a template that guides the development of skeletal tissues [1]. Processes leading from the 
biosynthesis of pro-α1(II) chains in cells to the formation of collagen fibrils in the extracellular space are 
complex and include: (i) posttranslational modifications of nascent pro-α1(II) chains, (ii) their folding 
into triple-helical procollagen molecules and secretion from cells, and (iii) self-assembly of collagen 
molecules into fibrils [2].  
 Fundamental for the mechanical and biological functions of collagen II is its stable triple-helical 
conformation. Such a conformation is achieved by the folding of individual pro-α1(II) chains whose main 
collagenous domain consists of uninterrupted repetitions of the G-X-Y motif in which the “X” and the 
“Y” positions are frequently occupied by proline and hydroxyproline residues, respectively [2]. The 
accurate amino acid sequence of collagen II is critical for the correct functions of this protein at the tissue 
level and mutations in COL2A1 (OMIM#120140) are associated with a broad spectrum of 
chondrodysplasia phenotypes, generally described as spondyloepiphyseal dysplasia (SED), the main 
feature of which is abnormal skeletal development [3] 
One of the pathological consequences of mutations in collagenous proteins is a loss-of-function 
effect due to the reduced incorporation of mutants into the extracellular matrix (ECM). It has been 
suggested that the fundamental cause for the reduced amount of collagen molecules containing mutant α 
chains is excessive intracellular accumulation and subsequent degradation in a process described as 
"procollagen suicide" [4].  
Due to the possibility of excessive intracellular retention, some diseases that involve collagen 
mutants are categorized as storage diseases, a group that also includes diseases caused by the excessive 
accumulation of non-collagenous proteins, lipids, glycoproteins, and other macromolecules [5]. In our 
studies published elsewhere we demonstrated that the R789C and R992C substitutions in collagen II 
cause misfolding of mutant molecules, decrease their thermostabilities, promote excessive intracellular 
retention and aggregation, and increase apoptosis [6; 7; 8]. Thus, in addition to the loss-of-function effect, 
certain mutations in collagen II may also cause a gain-of-toxicity effect.  
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 Here, we studied the feasibility of reducing cellular stress associated with the R789C and R992C 
substitutions by stabilizing the mutant molecules and decreasing their intracellular accumulation. 
Employing glycerol and trimethylamine N-oxide (TMAO), chemicals that stabilize the collagen triple 
helix, we demonstrated that these compounds increase the thermostability of the R789C and R992C 
mutants, decrease their intracellular retention, and improve cell survival [9; 10; 11],. Our study provides 
bases for considering triple helices of thermolabile collagen mutants a new target to reduce the deleterious 
effects caused by their atypical retention. 
 
Materials and Methods 
 Mutation nomenclature -- The amino acid substitutions are named according to the literature, with 
amino acid residues numbered from the first glycine of the collagen II triple helix.  
 
 Procollagen II mutants -- Procollagen II mutants employed in this study are associated with SED 
[12; 13]. To facilitate various biochemical and microscopic assays, wild type (WT) and mutant 
procollagen II variants were engineered as chimeras fused with green fluorescent protein (Pro-GFP), as 
described [6; 8].  
 
 Cells expressing collagen II mutants -- For the production of Pro-GFP variants in quantities 
sufficient for assays of their thermostability, these proteins were expressed in HT-1080 cells (ATCC; 
CCL-121), as described [6; 8; 14]. For analyses of cellular responses to the presence of procollagen II 
mutants, the chondrocytic cell line SW-1353 (ATCC; HTB-94) was employed, as described [6; 7; 8]. 
Both cell lines were cultured in Dulbecco's Modified Eagle Medium supplemented with 10% fetal bovine 
serum and 40 µg/ml of L-ascorbic acid phosphate magnesium salt (Wako Chemicals, Inc.), as described 
[8; 14]. 
 
 Cell culture in the presence of glycerol and TMAO -- Glycerol and TMAO, compounds with 
chemical chaperone characteristics, were employed to determine the effects of their collagen-stabilizing 
activities on the structure of the R789C and R992C mutants, and the faith of cells harboring them. For 
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analyses of cell survival, we followed the experimental design described by Hintze et al [7]. In brief, SW-
1353 cells were cultured for 12 days post-confluence, and then cell culture media were supplemented with 
glycerol added to a final concentration of 0.1 M or 0.5 M, or TMAO added at 30 mM or 0.1 M. 
Subsequently, cell culture was continued for five additional days. After the five-day treatment, cell 
culture media and cell lysates were collected for further assays. For thermostability analyses, collagen II 
variants were isolated from HT-1080 cells cultured in the presence of 0.5 M glycerol or 0.1 M TMAO, as 
described [14].  
 Working concentrations of selected compounds used in this study were determined in pilot 
experiments. In these experiments cells were cultured in increasing concentrations of glycerol or TMAO. 
During culture, cells were monitored for proliferation, changes in morphology, and production of 
procollagen II, as described [6; 8]. The highest concentrations that did not have any apparent negative 
effects on cultured cells were applied in the presented studies. 
 
 Cleaved poly-(ADP-ribose) polymerase (cPARP) and TdT-mediated dUTP Nick-End Labeling 
(TUNEL) assays -- Glycerol and TMAO-treated cells were analyzed for apoptotic markers, as described 
[7]. In these assays cPARP was detected in cell lysates by Western blot with primary rabbit anti-cPARP 
antibodies (Cell Signaling Technology, Inc.) and secondary anti-rabbit IgG conjugated to horseradish 
peroxidase (HRP; Sigma-Aldrich). The same nitrocellulose membranes were also probed for 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The relative amount of cPARP in the analyzed 
samples was determined by measuring the ratios of the pixel intensities of the cPARP-positive bands and 
GAPDH-positive bands. In any given group of cells, i.e. expressing GFP-tagged WT, R789C or R992C 
collagen II, the cPARP/GAPDH ratio derived from non-treated cells was considered 100%. Statistical 
significances of differences between the means calculated for the relative contents of cPARP in cells 
cultured in the presence vs. the absence of tested compounds were evaluated by the Student’s t test 
(GraphPad Software, Inc.). 
 In another set of experiments the presence of fragmented DNA was analyzed by TUNEL assays that 
utilize tetramethylrodamine (TMR) as a red fluorophore (Roche). Subsequently the apoptotic index, 
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defined as the percentage of TUNEL-positive nuclei out of the total number of DAPI-positive nuclei, was 
calculated for each analyzed group, as described [6; 7]. 
 
 Thermostability assays of collagen II variants -- Two experimental approaches were designed; (i) in 
the first approach we analyzed the thermostabilities of purified collagen II mutants produced by HT-1080 
cells cultured in the presence of 0.5 M glycerol or 0.1 M TMAO, and (ii) in the second approach these 
compounds were added to purified collagen II variants produced by cells cultured in the absence of these 
compounds. The thermostabilities were measured by brief protease digestion, as described [6; 15]. Based 
on collagen II-melting curves, we determined the temperatures at which the triple helical structure of 
analyzed collagens was preserved in 75% (Tm75), 50% (Tm50), and 25% (Tm25) of maximum.  
 
 Intracellular Pro-GFP variants produced in the presence of glycerol and TMAO -- We analyzed 
whether glycerol and TMAO-mediated stabilization of collagen molecules could also influence their 
intracellular accumulation. In brief, glycerol or TMAO-treated cells were lysed, and then Pro-GFP 
variants were detected by Western blot assays with an anti-GFP antibody, as described [6; 8]. The relative 
content of GFP-positive bands was assayed by densitometry. The results of measurements were 
normalized to GAPDH and plotted as a percent of the non-treated control (expressed as 100%). 
 We also studied the effects of glycerol and TMAO on the accumulation of collagen 
molecules misfolded due to inhibition of critical hydroxylation of proline residues by 2,2' 
dipyridyl (Sigma-Aldrich) [16]. The intracellular content of Pro-GFP variants produced in the 
presence of 2,2' dipyridyl was assayed as described above. 
 
Results 
 Apoptotic markers in cells harboring the R789C and R992C mutants cultured in the presence 
of glycerol and TMAO -- Cells cultured in the presence of 0.5 M glycerol or 0.1 M TMAO had a 
statistically significant decrease in the relative amount of cPARP, indicating an increase of cell survival 
(Fig. 1 and Supplementary Fig. S1). In the same experimental conditions, the overall amounts of Pro-GFP 
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produced by cells did not change (Fig. 1). The lower concentrations of these compounds used in the pilot 
studies did not have significant effects on relative amounts of cPARP (data not shown).  
 TUNEL analyses (Supplementary Fig. S2) of cells cultured in the presence of 0.5 M glycerol or 0.1 
M TMAO support the results of cPARP assays. Specifically, we determined that in comparison to the 
non-treated cells harboring the WT, R789C or the R992C mutants, the apoptotic indexes for cells cultured 
in the presence of 0.5 M glycerol decreased from 0.89% (±0.15 SEM), 3.45% (±0.73 SEM), and 0.96% 
(±0.12 SEM), to 0.82% (±0.14 SEM), 2.34% (±0.3 SEM), and 0.5% (±0.11 SEM), respectively. A similar 
trend was observed in an analogous experiment where cells were treated with 0.1 M TMAO. Specifically, 
we determined that in comparison to the non-treated cells harboring the WT, R789C or the R992C 
mutants (see above) the apoptotic indexes for cells cultured in the presence of 0.1 M TMAO decreased to 
0.56% (±0.14 SEM), 2.24% (±0.22 SEM), and 0.67% (±0.08 SEM), respectively. 
 
 
Thermostabilities of the R789C and R992C mutants produced by cells cultured in the presence of 
glycerol or TMAO -- In comparison to the non-treated controls, the thermostabilities of the WT collagen 
II and the analyzed mutants produced by cells cultured in the presence of 0.5 M glycerol or 0.1 M TMAO 
have increased (Fig. 2A, Supplementary Fig. 3S, and Tab. 1). Based on this observation, however, it has 
not been clear whether the thermostabilizing effect depended on intracellular interactions of glycerol and 
TMAO with newly synthesized pro-α1(II) chains or whether these compounds were able exert a 
stabilizing effect extracellularly. Thus, in another set of experiments, we first prepared collagen II 
variants isolated from cells cultured in the absence of chaperones. Next, purified collagens were exposed 
to these compounds for 24-h at 4°C, and then thermostability measurements were performed. Because the 
thermostabilities of analyzed mutants have increased, these assays suggest that intracellular interaction 
between the chemical chaperones and procollagen is not a defining factor in stabilizing the collagen II 
variants (Fig. 2B, Supplementary Fig. 3S, and Tab. 1). When comparing the thermostabilities of the 
collagen variants purified from cultures of cells grown in the presence of chaperones to those isolated 
from cells grown in chaperone-free media and treated with chaperones right before the stability assays, it 
is apparent that the increase in thermostability was greater in the latter group. (Fig. 2 and Tab. 1).  
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Note: As glycerol and TMAO do not change the enzymatic activities of trypsin and chymotrypsin, it 
is important to emphasize that the observed increase of thermostabilities of collagen II variants was not a 
result of the decrease of the enzymatic activities of employed proteases [17].  
 Intracellular accumulation of the R789C and R992C mutants -- We analyzed the intracellular 
content of Pro-GFP variants in the presence of glycerol and TMAO. In comparison to the non-treated 
controls, in cells treated with these compounds the relative amounts of the R789C and R992C variants 
were reduced (Fig. 3 and Fig. 4). Of note was the observation that in cells expressing the R789C mutant, 
partial degradation of this protein was observed.  
As shown in Fig. 3 and Fig. 4 adding 2,2' dipyridyl into the cell culture increased accumulation of 
Pro-GFP in all analyzed groups. Moreover, as evident by the presence of GFP-positive fragments, 
increased intracellular accumulation was associated with degradation of all Pro-GFP variants. In addition, 
in cells cultured in the presence of this compound, neither glycerol nor TMAO reduced the intracellular 
accumulation of the Pro-GFP variants (Fig. 3 and Fig. 4). 
 
Discussion 
Employing a simple experimental system, we tested whether adverse consequences of intracellular 
accumulation of the thermolabile R789C and R992C collagen II mutants could be partially reduced by 
improving their thermostabilities. The strategy proposed here was to employ glycerol and TMAO, 
compounds that at 1 M concentration increase the thermostability of collagen triple helices by 1°C and 
5°C, respectively [9; 10].  
We demonstrated that the presence of glycerol and TMAO was associated with reduction of the 
relative amounts of cPARP in cells harboring the R789C and R992C mutants. At the same time, the 
presence of these compounds did not affect the overall production of collagen II. In cells expressing WT 
collagen II, the relative amount of background-level cPARP also decreased, but this change was relatively 
small compared to that observed for cells harboring collagen II mutants. The decrease in the apoptotic 
indexes for cells expressing the R789C and R992C variants in the presence of glycerol and TMAO further 
corroborates the results of quantitative assays of cPARP. Changes in the relative amounts of apoptotic 
markers in cells cultured in the presence of glycerol or TMAO correlated with the decrease of the 
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intracellular pool of procollagen molecules, suggesting the increase of their secretion. Because the 
efficient secretion of procollagens depends on the formation of thermostable triple-helical structures, the 
decrease of intracellular accumulation of inherently thermolabile R789C and R992C procollagen II 
mutants in the presence of glycerol and TMAO further indicate the chaperone-like collagen-stabilizing 
effect of these compounds [6; 7; 16; 18; 19]. The collagen-stabilizing activity of selected chemical 
chaperones, however, is probably limited to mutant molecules with localized structural aberrations. This 
notion is based on the observation that collagen molecules whose structures are extensively misfolded due 
to the inhibition of hydroxylation of proline residues by 2,2' dipyridyl are not stabilized by selected 
chemical chaperones..  
The decrease in the intracellular accumulation of studied mutants indicates that the stabilizing effects 
of glycerol and TMAO were primarily a result of the intracellular influence of these compounds on the 
structure of a collagen triple helix. In comparison to the stabilities of collagen II variants purified from 
cell culture media of cells grown in the presence of glycerol or TMAO, the increase in the thermostability 
was even greater in another experimental group in which these compounds were added to the purified-
collagen samples before thermostability assays and remained in the analyzed samples during these assays. 
This apparent difference was most likely due to the partial reversal of the stabilizing effects in the first 
experimental group due to the decrease in the concentration of glycerol and TMAO occurring during the 
purification of collagen II.  
The concept of improving the structure of misfolded mutant proteins by employing chemical 
chaperones to reduce the harmful effects that such mutants have on cells and tissues has been proposed 
and tested with a number of proteins associated with various diseases [20; 21; 22; 23; 24]. Specific 
examples of such an approach include employing TMAO to reduce the effects of mutant keratins that 
cause various skin disorders and to restore the activity of mutant branched-chain α-ketoacid 
dehydrogenase associated with maple syrup urine disease [25; 26]. Moreover, chemical chaperones were 
shown to be effective in stabilizing the structure and accelerating the secretion of mutant proteins 
involved in cystic fibrosis and Huntington’s disease, as well as liver injury and emphysema caused by an 
α1-antytrypsin deficiency [27; 28; 29]. Although most studies on chemical chaperones as therapeutic 
agents were done in cell culture conditions, reduction of ER stress and restoration of glucose homeostasis 
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by administration of 4-phenylbutyric acid, yet another compound with chaperone-like activities, in a 
mouse model of type 2 diabetes was also demonstrated, thereby indicating a potential utility of chemical 
chaperones in vivo [30]. 
The studies presented here provide experimental evidence that the aberrant structure of collagen 
mutants could be considered a target for approaches aimed at reducing the harmful effects imposed by 
these mutants. Preliminary tests presented here focused on the thermolabile R789C and R992C collagen 
II mutants that are associated with apoptosis and whose structural alterations are readily detectable [6; 7; 
8; 31]. The structural and biological effects of these mutations, however, do not represent the full 
spectrum of potential effects that different mutations may impose. For instance, in cells expressing the 
thermostable R75C, R519C, and G853E collagen II mutants which are also associated with skeletal 
diseases, an increase in apoptosis was not readily apparent [7]. Thus, the question remains whether 
targeting the structure of collagens should be considered only for the thermolabile mutants or also for the 
thermostable mutants whose ER stress-related effects may be long-term and accumulative.  
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Table 1 
 
Thermostabilities of the R789C and R992C mutant in the presence of glycerol and TMAO. 
 
  
aTm75 
[°C] 
aTm50 
[°C] 
aTm25 
[°C] 
 
Collage
n II 
variant 
 
C 0.5M 
Glycerol 
0.1M 
TMAO 
C 0.5 M 
Glycerol 
0.1M 
TMAO 
C 0.5M 
Glycerol 
0.1M 
TMAO 
Ch
ap
er
o
n
es
 
ad
de
d 
du
rin
g 
ce
ll 
cu
ltu
re
 
WT 40.4 40.6 40.5 41.3 41.5 41.3 42.2 42.3 42.2 
R789C 37.7 37.8 37.9 38.6 38.6 38.7 39.6 39.5 39.6 
R992C 38.7 39.4 39.1 39.3 39.8 39.6 40.1 40.1 40.3 
           
Ch
ap
er
o
n
es
 
ad
de
d 
to
 p
ur
ifi
ed
 c
o
lla
ge
n
 is
o
la
te
d 
fro
m
 
n
o
n
-
tr
ea
te
d 
ce
lls
 
WT 40.4 41.0 41.5 41.5 43.0 43.4 42.7 44.9 45.2 
R789C 38.6 39.0 39.4 39.1 39.7 40.1 39.6 40.6 40.9 
R992C 38.5 39.2 38.7 39.3 40.0 39.7 40.2 40.7 40.6 
 
aTm75, Tm50, and Tm25 indicate the temperatures at which the triple helical structure of analyzed collagens 
was preserved in 75%, 50%, and 25% of maximum, respectively; C indicates control samples not treated 
with chemical chaperones. 
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Figure Legends 
 
Figure 1 - Relative amounts of Pro-GFP variants (A) and cPARP (B) in cells cultured in the presence of 
0.5 M glycerol or 0.1 M TMAO. The relative amounts of Pro-GFP and cPARP in specific groups of cells 
treated with glycerol or TMAO are compared corresponding control groups cultured in the absence of 
these compounds (controls expressed as 100%). Each point represents the mean value from multiple 
independent assays ± standard error of the mean (SEM). Symbols: WT, samples that include wild type 
Pro-GFP; R789C and R992C, Pro-GFP mutants; ns, not statistically significant; P values for statistically 
significant differences between means calculated for analyzed group and non-treated controls are also 
presented (expressed as 100%). 
 
Figure 2 – A, Assays of the thermostabilities of the WT, R789C, and R992C collagen II variants isolated 
from HT-1080 cells cultured in the presence of 0.5 M glycerol or 0.1 M TMAO. B, Similar assays of the 
thermostability of the WT, R789C, and R992C collagen II variants isolated from HT-1080 cells cultured 
in chaperone-free media. Proteins were isolated from the media then incubated with 0.5 M glycerol or 0.1 
M TMAO. 
 Following preincubation at increasing temperatures, collagen II samples were subjected to brief 
protease digestion. The digested samples were electrophoresed in 7.5% polyacrylamide gels in reducing 
conditions and then α1(II) chains were visualized by Western blot (Supplementary Figure S3). 
Subsequently, the relative pixel intensities of bands corresponding to α1(II) chains were measured by 
densitometry. Graphic representations of changes in the relative amount of triple-helical collagen II in 
response to increasing temperature are demonstrated (see Table 1). Symbols: WT, wild type collagen II; 
R789C and R992C, collagen II mutant harboring specific substitution; solid circles (●)and solid line, non-
treated control; open circles (○) and dashed line, group treated with 0.5 M glycerol; triangles (▲) and 
dotted lines, a group treated with 0.1 M TMAO.  
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Figure 3 - Intracellular pool of Pro-GFP variants in cells cultured in the presence of glycerol or TMAO 
with or without addition of 2,2' dipyridyl. A, Site-by-site comparison of Pro-GFP variants from cells 
grown in the presence (+) or the absence (-) of 2,2' dipyridyl but in the absence of glycerol and TMAO. B, 
Intracellular pool of the Pro-GFP variants in cells grown in the presence of glycerol or TMAO but 
without 2,2' dipyridyl. C, Intracellular pool of the Pro-GFP variants in cells grown in the presence of 2,2' 
dipyridyl and glycerol or TMAO. Symbols: WT, samples that include wild type Pro-GFP; R789C and 
R992C, Pro-GFP mutants. Symbols: C, controls grown in the absence of glycerol (G) or TMAO (T). 
 
Figure 4. Graphic representation of intracellular accumulation of Pro-GFP variants in cells cultured in the 
presence of glycerol or TMAO with or without addition of 2,2' dipyridyl. The relative amounts of Pro-
GFP in specific groups of cells treated with glycerol or TMAO are compared to control groups cultured in 
the absence of these compounds (controls expressed as 100%). Each point represents the mean value from 
multiple independent assays ± standard error of the mean (SEM). 
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